Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$347,687
+$8,043 QoQ
Shares Held
2,752
+12.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,574
of 2,266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Signal Advisors Wealth, LLC holds $29,778,924 across 9 Drug Manufacturers - General names. GILD ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,191 | $13,422,822 | |
| 2 | JNJ |
Johnson & Johnson
|
23,993 | $6,093,502 | |
| 3 | ABBV |
AbbVie Inc.
|
22,938 | $5,772,118 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,779 | $2,156,101 | |
| 5 | AMGN |
Amgen Inc
|
2,041 | $739,086 | |
| 6 | AZN |
Astrazeneca PLC
|
2,706 | $513,111 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,813 | $450,185 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,752 | $347,687 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $347,687 | 2,752 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $339,644 | 2,437 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||